16
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Growth hormone replacement does not elevate albuminuria in GH-deficient adults

, &
Pages 1-6 | Published online: 08 Jul 2009

  • Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab 2000; 26 Suppl 4: 64-6.
  • Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, de Zeeuw D, de Jong PE. Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. PREVEND Study Group. Prevention of REnal and Vascular ENd-stage Disease. Clin Chem Lab Med 2000; 38: 1107-10.
  • Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300.
  • De Boer H, Blok GJ, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995; 16: 63-86.
  • Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 1992; 37: 387-97.
  • Hirschberg R, Brunori G, Kopple JD, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 1993; 43: 387-97.
  • Christiansen JS, Gammelgaard J, Orskov H, Andersen AR, Telmer S, Parving HH. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 1981; 11: 487-90.
  • Christiansen JS, Gammelgaard J, Frandsen M, Orskov H, Parving HH. Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week. Diabetologia 1982; 22: 333-7.
  • Hoogenberg K, Sluiter WJ, Dullaart RP. Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency. Acta Endocrinol (Copenh) 1993; 129: 151-7.
  • Manelli F, Bossoni S, Burattin A, Doga M, Solerte SB, Romanelli G, Giustina A. Exercise-induced microalbuminuria in patients with active acromegaly: acute effects of slow-release lanreotide, a long-acting somatostatin analog. Metabolism 2000; 49: 634-9.
  • Dullaart RP, Meijer S, Marbach P, Sluiter WJ. Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. Eur J Clin Invest 1992; 22: 494-502.
  • Sasaki H, Takeda N, Kawamura I, Nishida Y, Kikuchi K, Tanaka M. Urinary albumin excretion in short children treated with recombinant human growth hormone. Clin Nephrol 1996; 46: 6-9.
  • Levine D, Kreitzer P, Freedman S, Trachtman H. Recombinant human growth hormone therapy does not increase microalbuminuria in children with short stature. Clin Endocrinol (Oxf) 1993; 39: 677-9.
  • Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1(8649): 1221-5.
  • Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998:83:379-81.
  • Beentjes JA, Tjeerdsma G, Sluiter WJ, Dullaart RP. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia. Clin Endocrinol (Oxf) 1996; 45: 391-8.
  • Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes 1990; 39: 761-7.
  • Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-7.
  • Hoogenberg K, Visser P, Marrink J, Sluiter WJ, Dullaart RP. Increased urinary IgG/albumin index in normoalbuminuric insulin-dependent diabetic patients: a laboratory artefact. Diabet Med 1996; 13: 651-5.
  • Fomsgaard A, Feldt-Rasmussen B, Decken M, Dinesen B. Micro-ELISA for the quantitation of human urinary IgG. Scand J Clin Lab Invest 1987; 47: 195-8.
  • Dullaart RP, Roelse H, Sluiter WJ, Doorenbos H. Variability of albumin excretion in diabetes. Neth J Med 1989; 34: 287-96.
  • De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996; 81: 1371-7.
  • Feld S, Hirschberg R. Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 1996; 17: 423-80.
  • Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM, editor. The kidney. Philadelphia: WB Saunders; 1996. p. 1137-74.
  • Hoogenberg K, ter Wee PM, Lieverse AG, Sluiter WJ, Dullaart RP. Insulin-like growth factor I and altered renal hemodynamics in growth hormone deficiency, acromegaly, and type I diabetes mellitus. Transplant Proc 1994; 26: 505-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.